Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02348008
What this trial is testing

Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:

Who this might be right for
Clear Cell Renal Carcinoma
Arkadiusz Z. Dudek, MD 61
Testing effectiveness (Phase 2)Study completedNCT06493240
What this trial is testing

Neoadjuvant Long-course Chemoradiotherapy Followed by Immunotherapy for Locally Advanced Mid-low Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02904226
What this trial is testing

JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors

Who this might be right for
Cancer
Jounce Therapeutics, Inc. 242
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295317
What this trial is testing

PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714317
What this trial is testing

Phase Ib/II Multicenter Randomized Control Study of Peri-operative Treatment With Combination of CTLA-4, PD-1 Antibodies and Bevacizumab in Resectable HCC (Prophet)

Who this might be right for
Resectable Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 90
Early research (Phase 1)Study completedNCT04215978
What this trial is testing

Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma (HNSCC)+1 more
BeiGene 204
Testing effectiveness (Phase 2)Looking for participantsNCT07751055
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University 51
Testing effectiveness (Phase 2)Looking for participantsNCT03736889
What this trial is testing

Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors

Who this might be right for
MSI-H/dMMR Solid Tumors
BeiGene 200
Testing effectiveness (Phase 2)UnknownNCT06394791
What this trial is testing

Evaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute Obstruction

Who this might be right for
Left-sided Colorectal Cancer Complicating Acute Obstruction
The First Affiliated Hospital with Nanjing Medical University 27
Testing effectiveness (Phase 2)UnknownNCT03903887
What this trial is testing

Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05943795
What this trial is testing

A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Who this might be right for
Non-small Cell Lung AdenocarcinomaSquamous Cell Carcinoma of Lung
Sichuan Baili Pharmaceutical Co., Ltd. 589
Large-scale testing (Phase 3)Study completedNCT03409614
What this trial is testing

Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Regeneron Pharmaceuticals 789
Testing effectiveness (Phase 2)Looking for participantsNCT05098119
What this trial is testing

Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)

Who this might be right for
Oral Cavity Squamous Cell CarcinomaOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 43
Testing effectiveness (Phase 2)Looking for participantsNCT07371234
What this trial is testing

Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Rui You 22
Not applicableLooking for participantsNCT07291063
What this trial is testing

Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA

Who this might be right for
Cholangiocarcinoma
Shanghai Zhongshan Hospital 50
Testing effectiveness (Phase 2)Study completedNCT04821765
What this trial is testing

Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer

Who this might be right for
Esophagus CancerChemoradiotherapyOligometastatic Disease+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 35
Testing effectiveness (Phase 2)UnknownNCT03987698
What this trial is testing

Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 90
Large-scale testing (Phase 3)Looking for participantsNCT06791512
What this trial is testing

MFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC

Who this might be right for
Colorectal Cancer (CRC)pMMR/MSS Adenocarcinoma of the Colon or Rectum
Jun Huang 166
Early research (Phase 1)Active Not RecruitingNCT02989636
What this trial is testing

Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma

Who this might be right for
Chordoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Testing effectiveness (Phase 2)UnknownNCT04498689
What this trial is testing

Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Fudan University 117
Next Page